The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of TQB3728 tablets, an oral inhibitor of apoptosis proteins in patients with advanced solid tumor.
 
Qiufan Zheng
No Relationships to Disclose
 
Su Li
No Relationships to Disclose
 
Wen Xia
No Relationships to Disclose
 
Ruoxi Hong
No Relationships to Disclose
 
Kuikui Jiang
No Relationships to Disclose
 
Jiajia Huang
No Relationships to Disclose
 
Fei Xu
No Relationships to Disclose
 
Lifan Tu
Employment - Chia Tai Tianqing Pharmaceutical Group
 
Shaonan Tang
Employment - Chia Tai Tianqing Pharmaceutical Group
 
Mengjia Huang
Employment - Chia Tai Tianqing Pharmaceutical Group
 
Shusen Wang
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo
Speakers' Bureau - AstraZeneca; Lilly; Novartis; Pfizer; Roche
Research Funding - AstraZeneca; Pfizer